Free Trial

Jasper Therapeutics (JSPR) Insider Trading & Ownership

Jasper Therapeutics logo
$21.57 +0.04 (+0.19%)
(As of 12/20/2024 05:16 PM ET)

Jasper Therapeutics (NASDAQ:JSPR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.70%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$4.53 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$84,546.00
Get JSPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

JSPR Insider Buying and Selling by Quarter

Jasper Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/12/2024Jeetinder Singh MahalCOOSell900$22.11$19,899.00  
9/12/2024Jeetinder Singh MahalCOOSell900$21.23$19,107.00  
6/12/2024Jeetinder Singh MahalCOOSell900$24.16$21,744.00  
3/12/2024Jeetinder Singh MahalCOOSell900$26.44$23,796.00  
2/8/2024Velan Capital Investment ManagMajor ShareholderBuy350,000$12.95$4,532,500.00  
(Data available from 1/1/2013 forward)

JSPR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Jasper Therapeutics includes Anna Louise French, Carlyle Group Inc., Holding Ltd Roche, Jeetinder Singh Mahal, Thomas G Wiggans, Velan Capital Investment Manag, and William Lis. Learn more on insiders at JSPR.

2.70% of Jasper Therapeutics stock is owned by insiders. Learn more on JSPR's insider holdings.

The following insiders have purchased JSPR shares in the last 24 months: Carlyle Group Inc. ($4,699,995.00), Thomas G Wiggans ($12,300.00), and Velan Capital Investment Manag ($4,532,500.00).

Insiders have purchased a total of 665,333 JSPR shares in the last 24 months for a total of $9,244,795.00 bought.

The following insiders have sold JSPR shares in the last 24 months: Anna Louise French ($10,360.00), Holding Ltd Roche ($141,750.00), Jeetinder Singh Mahal ($99,486.00), and William Lis ($6,766.00).

Insiders have sold a total of 13,496 Jasper Therapeutics shares in the last 24 months for a total of $258,362.00 sold.

Jasper Therapeutics Key Executives

  • Mr. Ronald A. Martell (Age 62)
    President, CEO & Director
    Compensation: $892.45k
  • Mr. Herbert C. Cross (Age 52)
    CFO & Corporate Secretary
  • Dr. Luca Di Noto Ph.D.
    Senior Vice President of Technical Operations
  • Mr. David Ku M.D.
    Vice President of Corporate Development, Portfolio Strategy & Management
  • Mr. Matthew Ford
    Vice President of Human Resources
  • Dr. Wendy Pang M.D.
    Ph.D., Senior Vice President of Research & Translational Medicine
  • Dr. Edwin Jonathan Tucker M.D. (Age 52)
    Chief Medical Officer
  • Ms. Patricia Carlos
    Senior Vice President of Regulatory Affairs & Quality


This page (NASDAQ:JSPR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners